# A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)

> **NCT00140946** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 546 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MK0476; montelukast sodium/Duration of Treatment: 16 weeks
- **DRUG:** Comparator: placebo / Duration of Treatment: 16 weeks

## Key facts

- **NCT ID:** NCT00140946
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-03
- **Primary completion:** 2000-10
- **Final completion:** 2000-10
- **Target enrollment:** 546 (ACTUAL)
- **Last updated:** 2022-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00140946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00140946, "A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00140946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*